HBsAg seroconversion in chronic HBV patients treated with pegylated interferon alpha-2b alone or in combination with lamivudine. The role of HBV genotype.

被引：0
|
作者：
Flink, HJ
van Zonneveld, M
Niesters, HGM
de Man, RA
Schalm, SW
Janssen, HLA
机构：
[1] Erasmus MC Univ, Dept Gastroenterol & Hepatol, Rotterdam, Netherlands
[2] Erasmus MC Univ, Dept Virol, Rotterdam, Netherlands
来源：
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY | 2005年 / 17卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：A49 / A49
页数：1
相关论文
共 50 条
  • [1] HBsAg seroconversion in chronic HBV patients treated with pegylated interferon alpha-2b alone or in combination with lamivudine. The role of HBV genotype
    Janssen, HL
    Flink, HJ
    van Zonneveld, M
    Niesters, HG
    de Man, RA
    Schalm, SW
    HEPATOLOGY, 2004, 40 (04) : 660A - 660A
  • [2] Exacerbation of chronic hepatitis B in relation to genotype and response of treatment with pegylated interferon alone or its combination with lamivudine.
    Flink, HJ
    van Zonneveld, M
    Niesters, HGM
    de Man, RA
    Schalm, SW
    Janssen, HLA
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2005, 17 (01) : A13 - A13
  • [3] HBV viral dynamics during treatment of naive patients with HBeAg(-) chronic hepatitis B with pegylated interferon alpha 2b alone or in combination with lamivudine
    Sypsa, V
    Mimidis, K
    Tassopoulos, NC
    Chrysagis, D
    Vassiliadis, T
    Moulakakis, A
    Raptopoulou, M
    Haida, C
    Hatzakis, A
    HEPATOLOGY, 2004, 40 (04) : 668A - 669A
  • [4] HBV recurrence in chronic hepatitis B treated with lamivudine after prolonged seroconversion and long-term treatment with lamivudine.
    Gutfreund, KS
    Addison, WR
    Williams, M
    Fischer, KP
    Tyrrell, DLJ
    HEPATOLOGY, 1998, 28 (04) : 487A - 487A
  • [5] Quantification of HBsAg and HBV-DNA during Therapy with Peginterferon alpha-2b plus Lamivudine and Peginterferon alpha-2b Alone in a German Chronic Hepatitis B Cohort
    Wiegand, J.
    Brosteanu, O.
    Kullig, U.
    Wiese, M.
    Berr, F.
    Maier, M.
    Tillmann, H. L.
    Schiefke, I.
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2011, 49 (11): : 1463 - 1469
  • [6] The role of HBV genotype in the emergence of YMDD variants in chronic hepatitis B patients treated with lamivudine
    Valdes, CA
    Buti, M
    Costa, X
    Jardi, R
    Rodriguez, F
    Mesas, I
    Esteban, R
    Guardia, J
    JOURNAL OF HEPATOLOGY, 2003, 38 : 178 - 178
  • [7] Virological analysis of chronically infected HBeAg positive HBV patients treated with a combination of pegylated interferon ALFA-2B and lamivudine
    Niester, HGM
    Janssen, HLA
    Pas, SD
    Copra, C
    de Man, RA
    Schalm, SW
    Osterhaus, ADME
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2004, 6 (02): : 154 - 154
  • [8] Liver histology in chronic hepatitis B patients after 1 year of treatment with pegylated interferon alpha-2b in combination with lamivudine or placebo
    van Zonneveld, M
    Zondervan, P
    de Man, RA
    Schalm, SW
    Janssen, HLA
    JOURNAL OF HEPATOLOGY, 2004, 40 : 132 - 132
  • [9] EFFICACY AND SAFETY OF PEGYLATED INTERFERON ALPHA-2b IN HBV POSTPARTUM WOMEN WITH LOW HBsAg LEVELS: AN EXPLORATORY STUDY IN SOUTHWEST CHINA
    Guo, Yan
    Jiang, Li
    Liu, Ming
    Zhu, Yan
    Wu, Yi
    Xia, Jie
    Deng, Guohong
    Mao, Qing
    HEPATOLOGY, 2023, 78 : S514 - S515
  • [10] Liver histology in chronic hepatitis B patients after 1 year of treatment with pegylated interferon alpha-2b in combination with lamivudine or placebo.
    van Zonneveld, M
    Zondervan, P
    de Man, RA
    Schalm, SW
    Janssen, HLA
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2005, 17 (01) : A13 - A13
12345